| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $64.0M | +21.5% |
| Cost of Revenue | $61.5M | +89.4% |
| Gross Profit | $2.5M | -87.5% |
| R&D Expense | $14.8M | -2.4% |
| SG&A Expense | $18.2M | -0.7% |
| Operating Income | -$43.2M | -226.5% |
| Pre-tax Income | -$38.9M | -260.3% |
| Income Tax | $2.0M | +11.1% |
| Net Income | -$39.8M | -226.5% |
| EPS (Basic) | -$1.49 | -217.0% |
| EPS (Diluted) | -$1.49 | -217.0% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.1M | -12.3% |
| Short-term Investments | $22.1M | +27.0% |
| Accounts Receivable | $11.2M | -40.1% |
| Inventory | $12.3M | -71.8% |
| Current Assets | $92.0M | -31.0% |
| Total Assets | $109.7M | -29.9% |
| Current Liabilities | $20.1M | -38.0% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.9M | +122.6% |
| Investing Cash Flow | -$14.7M | -180.2% |
| Financing Cash Flow | $432K | +169.2% |
| Stockholders' Equity |
| $78.1M |
| -32.4% |